An Implementation Science Assessment of Intranasal Esketamine's Limited Integration into Mainstream Psychiatric Treatment.
The journal of behavioral health services & research October 19, 2025 Benjamin Anderson, Megan O'Grady
Major Depressive Disorder is one of the most common mental illnesses worldwide, with oral antidepressant medication being the first-line psychopharmacological treatment option. The term Treatment Resistant Depression (TRD) is used to describe patients who remain symptomatic despite multiple trials of antidepressant medication. There had been limited FDA-approved treatment options for patients...